29
Nosocomial Nosocomial Urinary Infections Urinary Infections Nosocomial Nosocomial Urinary Infections Urinary Infections Hani Hani Jokhdar Jokhdar, MD. , MD. Consultant of Communicable Disease Control Consultant of Communicable Disease Control Consultant of Communicable Disease Control Consultant of Communicable Disease Control

Infeksi Saluran Kemih

Embed Size (px)

DESCRIPTION

ppi

Citation preview

Page 1: Infeksi Saluran Kemih

NosocomialNosocomial Urinary InfectionsUrinary InfectionsNosocomialNosocomial Urinary InfectionsUrinary Infections

Hani Hani JokhdarJokhdar, MD., MD.Consultant of Communicable Disease ControlConsultant of Communicable Disease ControlConsultant of Communicable Disease ControlConsultant of Communicable Disease Control

Page 2: Infeksi Saluran Kemih

Case oneCase one

An An 60 60 y.oy.o. female admitted to the ICU. female admitted to the ICU2727//99//0606 k f CVA d tik f CVA d tion on 2727//99//0606; known case of CVA, dementia,; known case of CVA, dementia,

bedsore and hypothyroidism.bedsore and hypothyroidism.A i d th f ll iA i d th f ll iAcquired the following:Acquired the following:

44//1010//0606; UTI ; UTI Pseudomonas a. ESBL Pseudomonas a. ESBL t t d itht t d ith MMtreated with treated with MeropenemMeropenem1010//1010//0505; Extension of infection to ; Extension of infection to

dd b t ib t i ((P dP dsecondary secondary baceteremiabaceteremia ((Pseudomonas Pseudomonas a.) a.) treated with treated with MeropenemMeropenem and and GentamicinGentamicinGentamicinGentamicin

Page 3: Infeksi Saluran Kemih

1818//1111//0606; Bedsore get heavily colonized ; Bedsore get heavily colonized ((E. coli E. coli andand Proteus M.Proteus M.))(( ))2626//1111//0606; UTI (; UTI (E. coliE. coli) treated with ) treated with GentamicinGentamicinGentamicinGentamicin2626//1010//0606; vaginal infection (; vaginal infection (E. coliE. coli))

Page 4: Infeksi Saluran Kemih

Th t t l t f thTh t t l t f thThe total money spent for the The total money spent for the treatment of the previous HAtreatment of the previous HAtreatment of the previous HA treatment of the previous HA

UTI and its consequencesUTI and its consequenceswas > was > 5050,,000 000 SRSR

Page 5: Infeksi Saluran Kemih

Case twoCase two

54 54 y.oy.o male, admitted on male, admitted on 1717//1212//06 06 yy ,, // //Acute MI; Known IHD & cirrhotic liverAcute MI; Known IHD & cirrhotic liverOccupied ICU bed until death on MarchOccupied ICU bed until death on MarchOccupied ICU bed until death on March Occupied ICU bed until death on March 2020thth. . A i d th f ll iA i d th f ll i UTIUTI ith thith thAcquired the following Acquired the following UTIsUTIs with the with the following organisms throughout following organisms throughout h it li tih it li tihospitalizationhospitalization

ESBL pseudomonas a. ESBL pseudomonas a. treated with treated with 3 3 antibiotic for antibiotic for 3 3 weeks. weeks.

Page 6: Infeksi Saluran Kemih

EnterobacterEnterobacter alsoalso ESBLESBL that was treatedthat was treatedEnterobacterEnterobacter alsoalso ESBL ESBL that was treated that was treated with with GentamicinGentamicinThe patient has also colonized hisThe patient has also colonized hisThe patient has also colonized his The patient has also colonized his sputum with MDR sputum with MDR AcinetobacterAcinetobacter spp. spp. Which was demonstrated in urine twoWhich was demonstrated in urine twoWhich was demonstrated in urine two Which was demonstrated in urine two days prior to death.days prior to death.

Page 7: Infeksi Saluran Kemih

IntroductionIntroduction

Th th i f ti i d i thTh th i f ti i d i thThey are the infections acquired in the They are the infections acquired in the hospital after admissionhospital after admission

NIPatient’s own flora

Other patient Environment

Medical equipmentNI

Staff member

Page 8: Infeksi Saluran Kemih

The alertThe alert

With the best hospital care; medical statistics p ;demonstrates that at least 10% of total hospital admission end up with nosocomial infectionsp

Nearly 100,000 people die of NI in the USANearly 100,000 people die of NI in the USAeach year

Adding an extra 4 days of hospital stay costing an average of $2000 per patientg p p

Page 9: Infeksi Saluran Kemih

It is increasing: why?It is increasing: why?

The widespread use of antimicrobial in thephospitals together with the easy access in pharmacies led to emergence of resistant strainsp g

Failure to follow appropriate infection controli h it l ttimeasures in hospital settings

Increase in the number of theimmunocompromised in hospitals

Page 10: Infeksi Saluran Kemih

More people undergoing extensive invasiveMore people undergoing extensive, invasive surgical procedure

Increase demand for blood transfusion

Increasing renovation in the aged hospital b ildibuilding

Page 11: Infeksi Saluran Kemih

Main Types of InfectionsMain Types of Infections

44%

17% UTISSI44%

18%

SSIBSIP

11%10%

18% PneumoOthers

11%

Page 12: Infeksi Saluran Kemih

HA HA -- UTIUTI

It is the most common type (± 40%) of NIinvolving both LTC and acute hospital settings

Instrumentation is almost always associated ith llwith all cases

Being the most common it is the most gpreventable

Adults and children are equally affected

Page 13: Infeksi Saluran Kemih

HistoryHistory

Frederick Foley in 1927First to control bleeding post-operativelyg p p yThen to drain the obstructed tractDrain incontinent patientM iMeasure urinary output

1950s and the close sterile drainage system1970 k th ti ill1970s knows the routine surveillance

Page 14: Infeksi Saluran Kemih

EpidemiologyEpidemiology

Catheter useCatheter useIt is an instrumentation that is almost used in all

h i lhospitals

Endemics occurs throughout the hospitalg p

The daily IR is 2-16% for the first 10 days in theclose system drainageclose system drainage

Universal infection by 30 days in the close d isystem drainage

Page 15: Infeksi Saluran Kemih

Cont…Cont…EpidemEpidem

Magnitude of the problemMagnitude of the problemg pg pIncidence and costIncidence and cost

1515 –– 2020 % of total hospital admission have FC% of total hospital admission have FC15 15 20 20 % of total hospital admission have FC% of total hospital admission have FCNearly Nearly 900900,,000 000 nosocomial UTI in the USnosocomial UTI in the USIt cost $It cost $600600 million if LOS increased bymillion if LOS increased by 11 daydayIt cost $It cost $600 600 million if LOS increased by million if LOS increased by 1 1 daydayIn reality LOS increased by average of In reality LOS increased by average of 33..8 8 days days costing $costing $33 billionbillioncosting $costing $3 3 billionbillion

Page 16: Infeksi Saluran Kemih

Cont…Cont…EpidemEpidem

MortalityMortalityRelated to Related to bacteremiabacteremia which accounts for which accounts for 00..3 3 –– 33..99% of total % of total UTIsUTIsOut of which fatality exceed Out of which fatality exceed 3030% (% (4500 4500 death/year)death/year)

MorbidityMorbiditySpread of infection through out urinary tract Spread of infection through out urinary tract causing; causing; absessesabsesses, , epididymitisepididymitis, , orchitisorchitis…etc.…etc.O h li i lik d lO h li i lik d lOther complications like stones and polyps Other complications like stones and polyps

Page 17: Infeksi Saluran Kemih

Consequences of antibiotic useConsequences of antibiotic useqqEmergence of resistant strainsEmergence of resistant strains

Epidemics of HA UTIEpidemics of HA UTIEpidemics of HA UTIEpidemics of HA UTIUrinary drainage bag act as a reservoir for Urinary drainage bag act as a reservoir for the organisms to colonize and to transfer thethe organisms to colonize and to transfer thethe organisms to colonize and to transfer the the organisms to colonize and to transfer the resistant plasmid resistant plasmid With poor hand hygiene crossWith poor hand hygiene cross--infection lead infection lead p ygp ygto hospital wide organismsto hospital wide organisms

Page 18: Infeksi Saluran Kemih

Etiologic AgentsEtiologic Agents

Fecal FloraFecal Flora

15%25%

7%

16%11%

8%

E.Coli Enterococcus P.aeruginosa C.albican K.Pneumoniae Others

Page 19: Infeksi Saluran Kemih

PathogenesisPathogenesis

Role of catheterTransurethral catheter break the normal defense mechanismTh i b ll l iThe retention balloon prevents complete emptyingOpen channel to the bladder

i b dForeign body

Page 20: Infeksi Saluran Kemih

Bacterial factorsBacterial factorsPiliPiliHemolysinHemolysin

UreaseUreaseUreaseUrease

Pathways of infectionPathways of infectionIntraluminal (exogenous organism)Intraluminal (exogenous organism)Intraluminal (exogenous organism)Intraluminal (exogenous organism)Extraluminal (endogenous organism)Extraluminal (endogenous organism)

Page 21: Infeksi Saluran Kemih

Host factorsHost factorsDuration of useDuration of useFemale genderFemale genderAbsence of systemic antibioticsAbsence of systemic antibioticsyyDMDMRenal insufficiency Renal insufficiency yyAdvanced ageAdvanced ageSevere underlying illnessesSevere underlying illnessesSevere underlying illnessesSevere underlying illnesses

Page 22: Infeksi Saluran Kemih

DiagnosisDiagnosis

CDC definition

Exclude infections that acquired prior to admission

Asymptomatic bacteriuia should have > 100,000 cfu/cchave 100,000 cfu/cc

Culturing the catheter tip is of NO VALUEg p

Uses of symptoms; only fever

Page 23: Infeksi Saluran Kemih

Specimen collectionSpecimen collection

It is preferable to obtain specimen from It is preferable to obtain specimen from new catheter rather than old catheternew catheter rather than old catheterUrine obtained through inserting needle Urine obtained through inserting needle into catheter or through diaphragminto catheter or through diaphragminto catheter or through diaphragm into catheter or through diaphragm For suprapubic and straight catheter; For suprapubic and straight catheter; specimen obtained directly from bladderspecimen obtained directly from bladderspecimen obtained directly from bladderspecimen obtained directly from bladder

Page 24: Infeksi Saluran Kemih

PreventionPrevention

Close sterile drainage system

Infection control and surveillance programsInfection control and surveillance programsGuidelines

Alternative to FC

Adjunct to closed drainage

Alternative to FC

Secondary prevention

Page 25: Infeksi Saluran Kemih

Surveillance dataSurveillance data

BenchmarkingBenchmarking

13 66 1416

9.19.43

13.66

11.0311.6

6 96 98.45

7 2 8101214

00 F

-day

s

6.96.26.97.2

3.43.43.83.64

0246

Per 1

00

0MarchFebruaryJanuaryDecemberNovember

Hospital 1 Hospital 2 Hospital 3p p p

Page 26: Infeksi Saluran Kemih

RecommendationRecommendation

Put your evidencePut your evidence--based IC guidelinesbased IC guidelinesHCW behavioral modificationHCW behavioral modificationDo your surveillance properlyDo your surveillance properlyo you u a p op yo you u a p op yBenchmark yourself overtimeBenchmark yourself overtimePI projectsPI projectsPI projectsPI projectsNNIS NNIS

Fully computerized patient recordsFully computerized patient recordsDataData--miningmining--derived epidemiologyderived epidemiology

Page 27: Infeksi Saluran Kemih
Page 28: Infeksi Saluran Kemih
Page 29: Infeksi Saluran Kemih